Treatment with bone-seeking radionuclides for painful bone metastases in patients with lung cancer: a systematic review

BMJ Supportive & Palliative Care
Helle D ZachoLars J Petersen

Abstract

Treatment with bone-seeking radionuclides may provide palliation from pain originating from bone metastases. However, most studies have been conducted in patients with prostate cancer and patients with breast cancer. We aimed to perform a systematic review of the use of radionuclide treatment in lung cancer in accordance with the PRISMA guidelines. In the eligible trials, pain relief was reported in 75% of the patients included in the studies. The onset of pain relief was seen within 1-5 weeks after treatment, lasting up to 6 months. However, the methodology in the included trials was poor-only two randomised trials were eligible, and none of them compared radionuclide treatments with placebo or best standard of care. The remaining trials were case series with inherent problems of methodology reporting. Particularly challenging was the lack of reporting of baseline disease status and use of prior/concomitant analgaesics. Large randomised controlled trials are needed to clarify the efficacy of radionuclide treatment in lung cancer.

References

Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Aug 11, 2005·Revue des maladies respiratoires·H RatsimanohatraP Astoul
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert E Coleman
Feb 17, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Nathan LawrentschukAndrew M Scott
May 7, 2011·Expert Opinion on Emerging Drugs·Flaminia ColuzziConsalvo Mattia
Jun 21, 2011·Cancer Treatment Reviews·Mette H Christensen, Lars J Petersen
Nov 1, 2011·International Journal of Surgery·David MoherUNKNOWN CONSORT
Apr 24, 2012·Cancer Letters·Jatinder Goyal, Emmanuel S Antonarakis
Aug 1, 2012·Expert Review of Anticancer Therapy·David Shapiro, Basir Tareen
Sep 8, 2012·Journal of the National Comprehensive Cancer Network : JNCCN·James L MohlerDorothy A Shead
Jan 23, 2013·The Cancer Journal·Darren BradyJoe M O'Sullivan
Feb 28, 2013·JAMA : the Journal of the American Medical Association·Melanie CalvertUNKNOWN CONSORT PRO Group
Jul 19, 2013·The New England Journal of Medicine·C ParkerUNKNOWN ALSYMPCA Investigators
Dec 11, 2013·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
May 2, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ColemanUNKNOWN ESMO Guidelines Working Group

❮ Previous
Next ❯

Citations

Jan 1, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lizza E L HendriksAnne-Marie C Dingemans
Apr 1, 2014·Archives of Medical Research·Luis Correa-GonzálezLuis Correa-Hernández

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Supportive and Palliative Care
Salil VengalilChristopher Parker
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica
G D'angeloG Mariani
© 2021 Meta ULC. All rights reserved